Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Sensex rises, Nifty ends at record high; RIL shares rally.
Special 301 Report expresses concern over weak IPR laws, to conduct reviews.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
India had been engaged in a contentious battle with the US over the issue, especially in the pharmaceutical sector.
The Nikkei share average rose 2.6% to close at 15,195.77 points, more than recouping Tuesday's losses.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
The Union health ministry on Friday said license has been given to five more manufacturers for production of Amphotericin-B, used in the treatment of black fungus, and they will start producing 1,11,000 vials of the drug per month from July.
Benchmark share indices ended lower for the third straight session as investors turned cautious amid tensions in Iraq even as consumer durables shares stole the limelight tracking rally in gold prices.
Sensex ends 134.91 pts down at 28,709.87; Nifty falls 44.70 pts at 8,712.05.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries:
Ajit Mishra, Vice President, Research, Religare Broking, answers readers' stock market queries. Ajit will offer his unbiased views on a weekly basis
Ajit Mishra, Vice President, Research, Religare Broking, answers readers's queries on stocks they own or want to buy.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances